13 May 2010 – interim management statement
After a slow start to the year, trading has picked up more recently although the company remains cautious in the short term. It does remain optimistic about medium and long term prospects though as its pharmaceutical customers become more active. The group continues to maintain a strong cash position and we retain our recommendation of SPECULATIVE BUY.